Peter Oppenheimer, the chief of global equity strategy and the head of macro research for Goldman Sachs in Europe, opined ...
Bernstein SocGen Group revised its price target for Regeneron (NASDAQ:REGN) Pharmaceuticals (NASDAQ: REGN) to $1,000 from the previous $1,070, while retaining an Outperform rating on the stock.
Alternative lending giant Goldman Sachs Asset Management is looking to raise as much as $3 billion for a new climate credit ...
Goldman Sachs analyst Neil Mehta downgraded Occidental Petroleum (OXY – Research Report) to a Sell today and set a price target of $45.00. The ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...